Breaking News

ExoCoBio to Build World’s First Clinical Grade Exosome GMP Mfg. Facility

Will invest approximately $20 million to install two types of advanced exosome production lines in Osong South Korea.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ExoCoBio Inc. initiated its “Project EGMP with the construction of the world’s first exosome-based drug manufacturing and R&D facility in Osong, Chungcheongbuk-do, South Korea. Osong serves as a bio-cluster to attract biotechnology businesses with government agencies like Korea FDA.   ExoCoBio will invest approximately $20 million to build the EGMP facility. After two years of preparation, its construction began in August this year.   This EGMP facility, a two-story building ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters